NCT06604234View on ClinicalTrials.gov

Impact of a Probiotic Combination on Quality of Life and Symptoms in Peri- and Postmenopausal Women

NACompletedINTERVENTIONAL

Enrollment

244

Participants

Timeline

Start Date

September 16, 2024

Primary Completion Date

December 14, 2024

Study Completion Date

January 17, 2025

Conditions

Menopause

Interventions

DIETARY_SUPPLEMENT

Probiotic

Combination of Levilactobacillus brevis KABP-052, Lactiplantibacillus plantarum KABP-051 and Pediococcus acidilactici KABP-021 in concentration of 1E09 CFU/capsule

OTHER

Placebo

Placebo comparator containing maltodextrin

Trial Locations (1)

28001

HM Gabinete Velázquez, Madrid

All Listed Sponsors

lead

AB Biotics, SA

INDUSTRY

NCT06604234 - Impact of a Probiotic Combination on Quality of Life and Symptoms in Peri- and Postmenopausal Women | Biotech Hunter | Biotech Hunter